Poseida Therapeutics
Stock Forecast, Prediction & Price Target
Poseida Therapeutics (PSTX) stock Price Target by analysts
$10
Potential upside: 4.82%
Poseida Therapeutics price prediction
What is Poseida Therapeutics stock analysts` prediction?
Poseida Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Poseida Therapeutics in the last 3 months, the avarage price target is $10, with a high forecast of $NaN. The average price target represents a 4.82% change from the last price of $9.54.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Poseida Therapeutics stock Price Target by analysts
Full breakdown of analysts given Poseida Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Edward Tenthoff Piper Sandler | 0% 0/1 | 10 months ago | $10 4.82% upside | $9.31 | StreetInsider | Previous targets (0) |
Unknown H.C. Wainwright | N/A | over 2 years ago | $15 57.23% upside | $5.79 | Benzinga | N/A |
Poseida Therapeutics Financial Estimates
Poseida Therapeutics Revenue Estimates
Poseida Therapeutics EBITDA Estimates
Poseida Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $31.23K N/A | $130.36M 417217.07% | $64.70M -50.36% | Avg: $28.75M Low: $12.77M High: $44.72M avg. -55.56% | Avg: $18.36M Low: $13.57M High: $23.56M avg. -36.11% | Avg: $101.79M Low: $75.24M High: $130.61M avg. 454.21% | Avg: $379.37M Low: $280.43M High: $486.81M avg. 272.70% |
Net Income
% change YoY
| $4.40M N/A | $-64.00M -1553.31% | $-123.43M -92.85% | Avg: $-226.47M Low: $-229.07M High: $-114.53M avg. -83.48% | Avg: $-218.36M Low: $-164.13M High: $-130.76M avg. 3.58% | Avg: $-101.00M Low: $-138.19M High: $-66.76M avg. 53.74% | Avg: $23.44M Low: $15.49M High: $32.08M avg. 123.21% |
EBITDA
% change YoY
| $-121.61K N/A | $-57.08M -46841.19% | $-109.03M -90.99% | Avg: $-2.51M Low: $-3.91M High: $-1.11M avg. 97.69% | Avg: $-1.60M Low: $-2.06M High: $-1.18M avg. 36.11% | Avg: $-8.91M Low: $-11.43M High: $-6.59M avg. -454.21% | Avg: $-33.22M Low: $-42.63M High: $-24.56M avg. -272.70% |
EPS
% change YoY
| $0.07 N/A | -$0.89 -1357.06% | -$1.37 -53.93% | Avg: -$1.8 Low: -$2.54 High: -$1.27 avg. -31.09% | Avg: -$1.58 Low: -$1.82 High: -$1.45 avg. 11.84% | Avg: -$1.12 Low: -$1.53 High: -$0.74 avg. 29.26% | Avg: $0.26 Low: $0.17 High: $0.36 avg. 123.21% |
Operating Expenses
% change YoY
| $172.64K N/A | $190.43M 110203.56% | $194.20M 1.97% | Avg: $23.09M Low: $10.26M High: $35.92M avg. -88.10% | Avg: $14.75M Low: $10.90M High: $18.93M avg. -36.11% | Avg: $81.76M Low: $60.43M High: $104.91M avg. 454.21% | Avg: $304.73M Low: $225.25M High: $391.03M avg. 272.70% |
FAQ
What is Poseida Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.26% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -229.07M, average is -226.47M and high is -114.53M.
What is Poseida Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 158.80% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $12.77M, average is $28.75M and high is $44.72M.
What is Poseida Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 33.30% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.54, average is -$1.8 and high is $-1.27.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Poseida Therapeutics stock. The most successful analyst is Edward Tenthoff.